SLC2A1 and primary central nervous system lymphoma: According to a Korean study, PCNSL patients expressed glucose transporter protein type 1 (GLUT1) in tumor tissues, and patients with > 20% GLUT1 positivity in lymphoma cells had shorter OS and more rapid disease progression [363].